sanofi pasteur

Public Trust In Vaccines Plummets After Dengvaxia Controversy

Confidence in vaccine safety and efficacy have declined precipitously following the Dengvaxia scandal in 2017.

The Philippines Pauses Dengue Vaccine Program

New findings indicate that vaccination could lead to more severe disease in people who have never had a prior dengue infection.

7 In 10 Indonesian Children Exposed To Dengue

In a study conducted on more than 3,000 Indonesian children from ages one to 18, nearly 70 percent tested positive for dengue antibodies, an indication that they have been infected before.

7 Must-Read Stories In November 2016

Gut-inspired batteries, dengue vaccines and future-proof jobs were popular reads last month.

What You Need To Know About Dengvaxia, Sanofi Pasteur’s Dengue Vaccine

Dr. Ng Su-Peing, global medical head of Sanofi Pasteur, explains how Dengvaxia can address the burden of dengue around the world.

7 Must-Read Stories In October 2016

Sanofi Pasteur's dengue vaccine, low-protein diets and a ‘light-stopping’ experiment were popular in October.

Great Hesitation In Adopting Dengue Vaccine

Dengxavia, the world's first approved dengue vaccine, has been rolled out in parts of Asia and South America—but doubts over its efficacy and potential for causing side effects remain.

A Shot In The Arm For Dengue Control?

The world's first dengue vaccine is good news, but not a perfect solution.

First Dengue Vaccine In Asia Approved In The Philippines

Dengvaxia®, the world's first dengue vaccine, has been approved for use in the Philippines.

Dengue Day 2015: Top Dengue Stories On Asian Scientist

Want to catch up on the latest happenings in dengue research over the past year? Look no further!